Hauck & Aufhaeuser set a €60.00 ($71.43) target price on Sartorius (FRA:SRT3) in a report released on Wednesday morning. The firm currently has a sell rating on the stock.

Other equities analysts also recently issued research reports about the stock. Berenberg Bank set a €85.00 ($101.19) price target on shares of Sartorius and gave the stock a buy rating in a report on Wednesday, October 25th. Warburg Research set a €100.00 ($119.05) price target on shares of Sartorius and gave the stock a buy rating in a report on Wednesday, October 25th. Commerzbank set a €87.00 ($103.57) price target on shares of Sartorius and gave the stock a neutral rating in a report on Tuesday, October 17th. UBS Group set a €85.00 ($101.19) price target on shares of Sartorius and gave the stock a neutral rating in a report on Tuesday, October 17th. Finally, Kepler Capital Markets set a €64.00 ($76.19) price target on shares of Sartorius and gave the stock a neutral rating in a report on Tuesday, October 17th. Three research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the company’s stock. The company presently has an average rating of Hold and a consensus target price of €78.40 ($93.33).

Sartorius (FRA:SRT3) traded down €0.10 ($0.12) on Wednesday, hitting €88.65 ($105.54). 57 shares of the stock traded hands. Sartorius has a 12-month low of €63.72 ($75.86) and a 12-month high of €94.00 ($111.90). The firm has a market capitalization of $6,350.00 and a P/E ratio of 72.07.

TRADEMARK VIOLATION WARNING: This article was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this article on another domain, it was stolen and republished in violation of U.S. and international trademark & copyright law. The original version of this article can be viewed at https://www.thecerbatgem.com/2018/01/11/hauck-60-00-price-target.html.

Sartorius Company Profile

Sartorius Aktiengesellschaft provides laboratory and process technologies and equipment worldwide. The company operates through two divisions, Bioprocess Solutions, and Lab Products & Services. The Bioprocess Solutions division offers products, technologies, and services ranging from fermentation, cell cultivation, filtration, and purification to media storage and transportation for the biopharmaceutical industry.

Analyst Recommendations for Sartorius (FRA:SRT3)

Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.